Gamma Pharmaceuticals' Jugular(R) Gets PO From Texas Distributor Worth $1,500,000 Retail Market Value
Published: Mar 27, 2009
LAS VEGAS, NV--(Marketwire - March 27, 2009) -
Gamma Pharmaceuticals Inc.
Commenting on this important news, Gamma's CEO Peter Cunningham said, "This is another key market opportunity for our Jugular® brand. The combination of Gamma's innovative products and promotion programs, TLED's distribution resources and existing customer base support should significantly expand Gamma's revenue. C-stores get the highest daily foot traffic which is important now as the retail landscape changes. C-stores are becoming more like supermarkets, pharmacies are becoming more like C-stores and supermarkets now offer all categories of grocery, sundry and OTC pharmacy products."
Gamma Pharmaceuticals Inc. is a marketing and product formulation company. Gamma creates, registers and brands innovative product lines including Nutritional Supplements, Personal Care Products and Over-The-Counter (OTC) pharmaceuticals. At present Gamma manufactures in North America, and distributes in the United States and China. Gamma's products utilize our proprietary "Gel Delivery Technology®," offering the industry's most innovative gel product forms, providing consumers a more pleasant experience with product forms that absorb more rapidly, are more convenient and taste great. Gamma targets market categories growing as rapidly as 60% per year.
Primary Channels are retail pharmacies, supermarkets, club stores and other big box outlets, as well as the U.S. Military. Secondary channels include Internet and direct selling. Gamma uses both third party distributors and direct sales to retail.
Gamma master brands include: Brilliant Choice® range of children's vitamins, nutritional supplements and immune boosters, and Savvy® a range of adult vitamin and nutritional products. Youth targeted products are sold under the brand Jugular® Energy -- "Go for the Jugular!™." In addition, Gamma sells IceDrop™ Instant Hand Sanitizer in China. Currently under development are formulas and strategies to address Metabolic Syndrome, Diabetes Type II, and general well-being products. Gamma also develops and manufactures house brands for major retailers. At this time, Gamma holds licenses for 9 SKUs in China.
Forward-Looking Statements: This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are subject to certain risks and uncertainties, and actual circumstances, events or results may differ materially from those projected in such forward-looking statements. The Company cautions readers not to place undue reliance on any forward-looking statements. The Company does not undertake, and specifically disclaims any obligation, to update or revise such statements to reflect new circumstances or unanticipated events as they occur.
Gamma Pharmaceuticals Inc.
651 204 2048
702 989 5262